Live Breaking News & Updates on Karyopharm Therapeutics Daily
Stay updated with breaking news from Karyopharm therapeutics daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Karyopharm Therapeutics (NASDAQ:KPTI – Free Report) had its price target cut by Royal Bank of Canada from $4.00 to $3.00 in a report published on Friday morning, Benzinga reports. They currently have an outperform rating on the stock. Several other equities analysts have also commented on the company. Wedbush reiterated a neutral rating and issued […] ....
Karyopharm Therapeutics (NASDAQ:KPTI – Get Free Report) had its price target dropped by Piper Sandler from $7.00 to $5.00 in a report released on Friday, Benzinga reports. The firm presently has an “overweight” rating on the stock. Piper Sandler’s target price would suggest a potential upside of 461.80% from the company’s current price. Other equities […] ....
Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Short Interest Up 10.6% in September kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Karyopharm Therapeutics Inc. (NASDAQ:KPTI – Get Free Report) saw a significant growth in short interest in the month of September. As of September 30th, there was short interest totalling 16,640,000 shares, a growth of 10.6% from the September 15th total of 15,040,000 shares. Based on an average trading volume of 2,150,000 shares, the days-to-cover ratio […] ....
Karyopharm Therapeutics Inc. (NASDAQ:KPTI – Get Free Report) has received a consensus rating of “Moderate Buy” from the five research firms that are presently covering the stock, Marketbeat reports. Two research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 12-month price objective […] ....